NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/17/2026
Back to search
Official data from USPTO
COHERUS ONCOLOGY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
COHERUS ONCOLOGY
ST13
US500000099289852Class
42, 44
Filing
99289852
Registration
8174778
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
03/17/2026
Classification
Registered
Trademark type
Word
Nice classes
42, 44
Filing date
07/17/2025
Registration date
03/17/2026
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/17/2026
Last transaction
03/17/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
05/30/2025
First use in commerce
05/30/2025
Drawing code
4
Owner type
03
Owner location
Redwood City, CA, US
Examiner
ROBERTSON, DEIRDRE G
Law office
M20
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
COHERUS ONCOLOGY, INC.
Representatives
Perry J Viscounty LATHAM & WATKINS LLP
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pharmaceutical research and development; Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Medical research; Medical research services in the field of cancer; Medical research in the field of oncology; Research and development of pharmaceuticals for the treatment of cancer; Providing information about medical research in the field of cancer
Class 44
Medical information; Providing information in the field of medicine; Consulting services in the field of medical care; Providing health information; Providing health information in the field of cancer treatment; Providing information in the field of cancer preventionscreeningdiagnosis and treatment
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/17/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/27/2026
PUBO
PUBLISHED FOR OPPOSITION
01/27/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/21/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/05/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/23/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/23/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/23/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/08/2025
GNRT
NON-FINAL ACTION E-MAILED
12/08/2025
CNRT
NON-FINAL ACTION WRITTEN
12/08/2025
DOCK
ASSIGNED TO EXAMINER
12/05/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/24/2025
MAFR
APPLICATION FILING RECEIPT MAILED
07/25/2025
NWAP
NEW APPLICATION ENTERED
07/17/2025
Continuous trademark protection
Get notified about every new filing that threatens COHERUS ONCOLOGY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.